Melanóma: vizsgálatok itt: Szlovákia

3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma

  Where

  Banská Bystrica

  Életkor

  18 év and over

  People

  632 worldwide

  Run by

  mAbxience Research S.L.

  See details and how to joinNCT07221734
• 3. fázisTaking people
  Randomised, Multicentre, Multinational, Double-Blind Integrated Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 (Proposed Nivolumab Biosimilar) Versus EU-/US-Opdivo in Subjects With Previously Untreated Advanced (Unresectable or Metastatic) Melanoma (LEON Study)

  Where

  Banska Bystrica

  Életkor

  18 év and over

  People

  119 worldwide

  Run by

  Mabxience Research S.L.

  See details and how to join2025-521562-95-00 · EU 2025-521562-95-00
• 3. fázisTaking people
  Neoadjuvant Darovasertib in Primary Uveal Melanoma

  Where

  Banská Bystrica

  Életkor

  18 év and over

  People

  520 worldwide

  Run by

  IDEAYA Biosciences

  See details and how to joinNCT07015190 · EU 2025-522387-32-00